JOHNSON & JOHNSON is 14.7x more valuable than TEVA PHARMACEUTICAL INDUSTRIES LTD by market capitalization ($573.98 B vs $39.12 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TEVA | JNJ |
|---|---|---|
| Market cap | $39.12 B | $573.98 B |
| US-listed rank | #392 | #20 |
| Revenue (latest FY) | $17.26B | $94.19B |
| Net income (latest FY) | $1.41B | $26.80B |
| Net margin | 8.2% | 28.5% |
| P/E (trailing FY) | 27.7 | 21.4 |
| SEC filings | 2,473 | 984 |
JOHNSON & JOHNSON is 14.7x more valuable than TEVA PHARMACEUTICAL INDUSTRIES LTD by market capitalization ($573.98 B vs $39.12 B).
In their latest fiscal years, TEVA PHARMACEUTICAL INDUSTRIES LTD reported $17.26B in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: TEVA PHARMACEUTICAL INDUSTRIES LTD and JOHNSON & JOHNSON, or browse the full rankings.